Elekta Infinity, a state-of-the art cancer radiation therapy technology with the addition of the Elekta Agility multileaf collimator (MLC) is offered at Mary Bird Perkins. Elekta Infinity is multifunctional and provides tailored solutions for complex patient needs.
Addition of the Agility MLC
The Agility MLC is a radiation beam shaping device integrated with the existing Elekta Infinity radiation therapy system, which is used for the treatment of many cancer types.
The Agility MLC works by using adjustable “leaves,” or shields, which can block a portion of the radiation beam to customize the shape of radiation treatment to a patient’s unique cancer.
Benefits of Agility MLC with Elekta’s Infinity linear accelerator
Patients currently undergoing radiation treatment at the Cancer Center are already receiving the benefits associated with the Agility MLC.
“We’re excited to offer this upgraded technology for our patients,” said Andrew Elson, M.D., radiation oncologist. “This state-of-the-art device allows us to more precisely limit radiation only to the affected area, minimizing the impact to nearby healthy tissue and improving outcomes and quality of life for our patients.”
- Patented technology that provides exquisite conformance to tumor size, shape and volume
- Delivery of high-definition radiation beams for both small and large, complex targets
- Shorter treatment times, resulting in increased patient comfort and convenience